The Malaria Synergy Program (MSP) brings together experts with complementary expertise into a multidisciplinary program to address major roadblocks to achieving the goals of malaria elimination in the Asia-Pacific region and globally.
The Malaria Synergy Program investigators and their teams will focus on developing novel approaches to optimise drug treatment, achieving highly efficacious and long-lasting vaccines, and developing novel tools to map and discover drivers of malaria transmission.
Our three core themes are:
- New tools to detect and target malaria transmission; develop multi-parameter tools to accurately measure malaria transmission and guide targeted interventions and predict the emergence and spread of drug resistance.
- Optimising drug treatments and combating resistance; optimise antimalarial combination therapies to treat drug-resistant P. falciparum malaria and develop strategies to better target P. vivax and clear dormant liver-stage infections.
- Maximising the efficacy and impact of vaccines; identify the key determinants of vaccine efficacy and longevity and define antigenic diversity of vaccine candidates and identify strategies to overcome vaccine escape.